FindTrial
Sign In

A clinical study on the effect of 3% diquafosol sodium and 0.1% sodium hyaluronate eye drops in the treatment of dry eye after SMILE surgery

A clinical study on the effect of 3% diquafosol sodium and 0.1% sodium hyaluronate eye drops in the treatment of dry eye after SMILE surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046019
Enrollment
Unknown
Registered
2021-05-02
Start date
2021-04-24
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia surgery

Interventions

Group 1:3% Diquafox Sodium
Group 2:0.1% Sodium Hyaluronate (HA)

Sponsors

The Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 41 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. No history of eye diseases and trauma; 3. The cornea is transparent without thin pans or spots; 4. Stop wearing soft contact lenses for more than 2 weeks or stop wearing rigid contact lenses for more than 4 weeks; 5. The annual increase in refractive power within 2 years is less than 0.5D.

Exclusion criteria

Exclusion criteria: 1. The thickness of the cornea cannot meet the requirements of surgery; 2. Keratoconus or suspicious keratoconus and other serious diseases of the eye and the whole body.

Design outcomes

Primary

MeasureTime frame
fluorescein break-up time (fBUT);schirmer I tests;dry eye related quality of life score(DEQS);uncorrected visual acuity;best corrected visual acuity;spherical equivalent;high-order aberrations;—

Countries

China

Contacts

Public ContactLi Ying

Second Affiliated Hospital of Harbin Medical University

liying1612@163.com+86 13503611612

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026